Search Results - "MOERTEL, C. G"

Refine Results
  1. 1

    Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer by O'Connell, M J, Laurie, J A, Kahn, M, Fitzgibbons, Jr, R J, Erlichman, C, Shepherd, L, Moertel, C G, Kocha, W I, Pazdur, R, Wieand, H S, Rubin, J, Vukov, A M, Donohue, J H, Krook, J E, Figueredo, A

    Published in Journal of clinical oncology (01-01-1998)
    “…This study had two major goals: (1) to assess the effectiveness of a regimen of fluorouracil (5-FU) plus levamisole plus leucovorin as postoperative surgical…”
    Get more information
    Journal Article
  2. 2

    Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A, Tangen, C M, Ungerleider, J S, Emerson, W A, Tormey, D C, Glick, J H

    Published in Journal of clinical oncology (01-12-1995)
    “…To determine the effectiveness of fluorouracil plus levamisole administered postoperatively to patients with resected stage II (Dukes' B2) colon cancer. This…”
    Get more information
    Journal Article
  3. 3

    Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma by Moertel, Charles G, Lefkopoulo, Myrto, Lipsitz, Stuart, Hahn, Richard G, Klaassen, David

    Published in The New England journal of medicine (20-02-1992)
    “…ADVANCED carcinoma of the islet cells of the pancreas, although rare, presents a kaleidoscope of clinical challenges. In addition to the usual problems…”
    Get full text
    Journal Article
  4. 4

    Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma by Poon, M A, O'Connell, M J, Moertel, C G, Wieand, H S, Cullinan, S A, Everson, L K, Krook, J E, Mailliard, J A, Laurie, J A, Tschetter, L K

    Published in Journal of clinical oncology (01-10-1989)
    “…The purpose of this study was to evaluate the effectiveness of several new approaches designed to enhance the activity of fluorouracil (5-FU) in the management…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    The management of patients with advanced carcinoid tumors and islet cell carcinomas by MOERTEL, C. G, JOHNSON, C. M, MCKUSICK, M. A, MARTIN, J. K, NAGORNEY, D. M, KVOLS, L. K, RUBIN, J, KUNSELMAN, S

    Published in Annals of internal medicine (15-02-1994)
    “…To determine the effectiveness of hepatic artery occlusion alone and with sequenced chemotherapy for patients with hepatic-dominant metastases of islet cell…”
    Get full text
    Journal Article
  8. 8

    Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A

    Published in Journal of clinical oncology (01-12-1993)
    “…To determine the frequency and nature of hepatic toxicity associated with fluorouracil (5-FU) plus levamisole adjuvant therapy. All patients had resection of…”
    Get more information
    Journal Article
  9. 9

    Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors by Trendle, Michael C., Moertel, Charles G., Kvols, Larry K.

    Published in Cancer (15-02-1997)
    “…BACKGROUND Octreotide, a long‐acting somatostatin analogue, has demonstrated clinical utility in patients with carcinoid syndrome and malignant islet cell…”
    Get full text
    Journal Article
  10. 10

    Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon by Moertel, C G, Rubin, J, Kvols, L K

    Published in Journal of clinical oncology (01-07-1989)
    “…Twenty-seven patients with metastatic carcinoid tumor, 24 of whom had the malignant carcinoid syndrome, were treated with recombinant leukocyte A interferon at…”
    Get more information
    Journal Article
  11. 11

    Cytoreductive hepatic surgery for neuroendocrine tumors by McEntee, G P, Nagorney, D M, Kvols, L K, Moertel, C G, Grant, C S

    Published in Surgery (01-12-1990)
    “…We retrospectively reviewed 37 patients who underwent hepatic resection between 1970 and 1989 to evaluate the role of cytoreductive hepatic surgery in patients…”
    Get more information
    Journal Article
  12. 12

    Treatment of the carcinoid tumor and the malignant carcinoid syndrome by Moertel, C G

    Published in Journal of clinical oncology (01-11-1983)
    “…Certainly in treatment of the carcinoid tumor surgery has a well-established curative and palliative potential. The primary challenge is a knowledgable…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue by Kvols, L K, Moertel, C G, O'Connell, M J, Schutt, A J, Rubin, J, Hahn, R G

    Published in The New England journal of medicine (11-09-1986)
    “…We studied the effects of a long-acting analogue of somatostatin (SMS 201-995, Sandoz) in 25 patients with histologically proved metastatic carcinoid tumors…”
    Get more information
    Journal Article
  16. 16

    Chemotherapy for Colorectal Cancer by Moertel, Charles G

    Published in The New England journal of medicine (21-04-1994)
    “…Carcinoma of the large bowel, which will afflict over 150,000 Americans this year, is second only to lung cancer as a cause of death from cancer 1 . Although…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The physician's responsibility toward hopelessly ill patients. A second look by Wanzer, S H, Federman, D D, Adelstein, S J, Cassel, C K, Cassem, E H, Cranford, R E, Hook, E W, Lo, B, Moertel, C G, Safar, P

    Published in The New England journal of medicine (30-03-1989)
    “…Physicians have a specific responsibility toward patients who are hopelessly ill, dying, or in the end stages of an incurable disease. In a summary of current…”
    Get more information
    Journal Article
  19. 19

    Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995) by Kvols, L K, Buck, M, Moertel, C G, Schutt, A J, Rubin, J, O'Connell, M J, Hahn, R G

    Published in Annals of internal medicine (01-08-1987)
    “…We used an octapeptide analogue of somatostatin, SMS 201-995, in dosages ranging from 150 to 450 micrograms/d administered subcutaneously in three daily doses…”
    Get more information
    Journal Article
  20. 20

    Carcinoid tumor of the appendix: treatment and prognosis by Moertel, C G, Weiland, L H, Nagorney, D M, Dockerty, M B

    Published in The New England journal of medicine (31-12-1987)
    “…In a long-term study of 150 unselected patients with carcinoid tumors of the appendix, we found that the neoplasms were usually less than 1.0 cm in largest…”
    Get more information
    Journal Article